Innate response activator B cells: Origins and functions

International Immunology

Volumn 27, Issue 10, 2015, Pages 537-541

  Chousterman, Benjamin G ^a   Swirski, Filip K ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

B1a cells; GM CSF; IgM; IL 3; innate immunity; IRA B cells

Indexed keywords

B CELL ACTIVATING FACTOR RECEPTOR; COLONY STIMULATING FACTOR 1; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN M; INTERLEUKIN 3; INTERLEUKIN 5; MYELOID DIFFERENTIATION FACTOR 88; TOLL LIKE RECEPTOR 4; IL3 PROTEIN, HUMAN;

ADAPTIVE IMMUNITY; ARTICLE; ATHEROSCLEROSIS; B LYMPHOCYTE; BACTERIAL INFECTION; BIOACCUMULATION; CELL FUNCTION; CHRONIC INFLAMMATION; CLINICAL TRIAL (TOPIC); DENDRITIC CELL; EXTRAMEDULLARY HEMATOPOIESIS; HUMAN; IMMUNE RESPONSE; INFLAMMATORY DISEASE; INNATE IMMUNITY; INNATE RESPONSE ACTIVATOR B LYMPHOCYTE; LEUKOCYTE ACTIVATION; LYMPHOID CELL; NATURAL KILLER CELL; NONHUMAN; ONTOGENY; PATHOPHYSIOLOGY; PHENOTYPIC VARIATION; PNEUMONIA; PRIORITY JOURNAL; SEPSIS; SPLEEN; ANIMAL; BIOSYNTHESIS; CELL LINEAGE; DISEASE MODEL; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; LUNG; MICROBIOLOGY; MOUSE; PATHOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; ATHEROSCLEROSIS; B-LYMPHOCYTE SUBSETS; CELL LINEAGE; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; IMMUNITY, INNATE; IMMUNOGLOBULIN M; INTERLEUKIN-3; LUNG; MICE; PNEUMONIA; SEPSIS; SIGNAL TRANSDUCTION; SPLEEN;

EID: 84946733588     PISSN: 09538178     EISSN: 14602377     Source Type: Journal    
DOI: 10.1093/intimm/dxv028     Document Type: Article

References (59)

1. Cooper, M. D., Peterson, R. D. and Good, R. A. 1965. Delineation of the thymic and bursal lymphoid systems in the chicken. Nature 205:143.
2. Cooper, M. D., Raymond, D. A., Peterson, R. D., South, M. A. and Good, R. A. 1966. The functions of the thymus system and the bursa system in the chicken. J. Exp. Med. 123:75.
3. Hardy, R. R., Kincade, P. W. and Dorshkind, K. 2007. The protean nature of cells in the B lymphocyte lineage. Immunity. 26:703.
4. LeBien, T. W. 2000. Fates of human B-cell precursors. Blood 96:9.
5. Jacob, J., Kelsoe, G., Rajewsky, K. and Weiss, U. 1991. Intraclonal generation of antibody mutants in germinal centres. Nature 354:389.
6. Kelsoe, G. 1996. Life and death in germinal centers (redux). Immunity 4:107.
7. Edelman, G. M. and Gally, J. A. 1964. A model for the 7S antibody molecule. Proc. Natl Acad. Sci. U. S. A. 51:846.
8. Porter, R. R. 1963. Chemical structure of gamma-globulin and antibodies. Br. Med. Bull. 19:197.
9. Brack, C., Hirama, M., Lenhard-Schuller, R. and Tonegawa, S. 1978. A complete immunoglobulin gene is created by somatic recombination. Cell 15:1.
10. Oettinger, M. A., Schatz, D. G., Gorka, C. and Baltimore, D. 1990. RAG-1 and RAG-2, adjacent genes that synergistically activate V(D)J recombination. Science 248:1517.
11. Schatz, D. G., Oettinger, M. A. and Baltimore, D. 1989. The V(D)J recombination activating gene, RAG-1 Cell. 59:1035.
12. Fidler, J. M. 1979. The induction of hapten-specific immunological tolerance and immunity in B lymphocytes. VI. Differential tolerance susceptibility in adult spleen as a function of B-cell maturation level. J. Exp. Med. 150:491.
13. Herzenberg, L. A., Black, S. J., Tokuhisa, T. and Herzenberg, L. A. 1980. Memory B cells at successive stages of differentiation. Affinity maturation and the role of IgD receptors. J. Exp. Med. 151:1071.
14. Takemori, T. and Tada, T. 1974. Selective roles of thymus-derived lymphocytes in the antibody response. II. Preferential suppression of high-affinity antibody-forming cells by carrier-primed suppressor T cells. J. Exp. Med. 140:253.
15. Baumgarth, N. 2011. The double life of a B-1 cell: self-reactivity selects for protective effector functions. Nat. Rev. Immunol. 11:34.
16. Hayakawa, K., Hardy, R. R., Parks, D. R. and Herzenberg, L. A. 1983. The "Ly-1 B" cell subpopulation in normal immunodefective, and autoimmune mice. J. Exp. Med. 157:202.
17. Fillatreau, S., Sweenie, C. H., McGeachy, M. J., Gray, D. and Anderton, S. M. 2002. B cells regulate autoimmunity by provision of IL-10. Nat. Immunol. 3:944.
18. Mizoguchi, A., Mizoguchi, E., Takedatsu, H., Blumberg, R. S. and Bhan, A. K. 2002. Chronic intestinal inflammatory condition generates IL-10-producing regulatory B cell subset characterized by CD1d upregulation. Immunity 16:219.
19. Mizoguchi, E., Mizoguchi, A., Preffer, F. I. and Bhan, A. K. 2000. Regulatory role of mature B cells in a murine model of inflammatory bowel disease. Int. Immunol. 12:597.
20. Yanaba, K., Bouaziz, J. D., Haas, K. M., Poe, J. C., Fujimoto, M. and Tedder, T. F. 2008. A regulatory B cell subset with a unique CD1dhiCD5+ phenotype controls T cell-dependent inflammatory responses. Immunity 28:639.
21. Barr, T. A., Shen, P., Brown, S. et al. 2012. B cell depletion therapy ameliorates autoimmune disease through ablation of IL-6-producing B cells. J. Exp. Med. 209:1001.
22. Flaishon, L., Becker-Herman, S., Hart, G., Levo, Y., Kuziel, W. A. and Shachar, I. 2004. Expression of the chemokine receptor CCR2 on immature B cells negatively regulates their cytoskeletal rearrangement and migration. Blood 104:933.
23. Honczarenko, M., Le, Y., Glodek, A. M. et al. 2002. CCR5-binding chemokines modulate CXCL12 (SDF-1)-induced responses of progenitor B cells in human bone marrow through heterologous desensitization of the CXCR4 chemokine receptor. Blood 100:2321.
24. Delogu, A., Schebesta, A., Sun, Q., Aschenbrenner, K., Perlot, T. and Busslinger, M. 2006. Gene repression by Pax5 in B cells is essential for blood cell homeostasis and is reversed in plasma cells. Immunity 24:269.
25. Zouggari, Y., Ait-Oufella, H., Bonnin, P. et al. 2013. B lymphocytes trigger monocyte mobilization and impair heart function after acute myocardial infarction. Nat. Med. 19:1273.
26. Schaniel, C., Pardali, E., Sallusto, F. et al. 1998. Activated murine B lymphocytes and dendritic cells produce a novel CC chemokine which acts selectively on activated T cells. J. Exp. Med. 188:451.
27. Rauch, P. J., Chudnovskiy, A., Robbins, C. S. et al. 2012. Innate response activator B cells protect against microbial sepsis. Science 335:597.
28. Bradley, T. R. and Metcalf, D. 1966. The growth of mouse bone marrow cells in vitro. Aust. J. Exp. Biol. Med. Sci. 44:287.
29. Dranoff, G., Crawford, A. D., Sadelain, M. et al. 1994. Involvement of granulocyte-macrophage colony-stimulating factor in pulmonary homeostasis. Science 264:713.
30. Stanley, E., Lieschke, G. J., Grail, D. et al. 1994. Granulocyte/macrophage colony-stimulating factor-deficient mice show no major perturbation of hematopoiesis but develop a characteristic pulmonary pathology. Proc. Natl Acad. Sci. U. S. A. 91:5592.
31. Dranoff, G. and Mulligan, R. C. 1994. Activities of granulocytemacrophage colony-stimulating factor revealed by gene transfer and gene knockout studies. Stem Cells. 12(Suppl. 1):173.
32. Hamilton, J. A. 2008. Colony-stimulating factors in inflammation and autoimmunity. Nat. Rev. Immunol. 8:533.
33. Hamilton, J. A. and Achuthan, A. 2012. Colony stimulating factors and myeloid cell biology in health and disease. Trends. Immunol 34:81.
34. Godin, I. E., Garcia-Porrero, J. A., Coutinho, A., Dieterlen-Lièvre, F. and Marcos, M. A. 1993. Para-aortic splanchnopleura from early mouse embryos contains B1a cell progenitors. Nature 364:67.
35. Wardemann, H., Boehm, T., Dear, N. and Carsetti, R. 2002. B-1a B cells that link the innate and adaptive immune responses are lacking in the absence of the spleen. J. Exp. Med. 195:771.
36. Ansel, K. M., Harris, R. B. and Cyster, J. G. 2002. CXCL13 is required for B1 cell homing, natural antibody production, and body cavity immunity. Immunity. 16:67.
37. Angus, D. C. and van der Poll, T. 2013. Severe sepsis and septic shock. N. Engl. J. Med. 369:2063.
38. Martin, G. S., Mannino, D. M., Eaton, S. and Moss, M. 2003. The epidemiology of sepsis in the United States from 1979 through 2000. N. Engl. J. Med. 348:1546.
39. Dolgin, E. 2012. Trial failure prompts soul-searching for criticalcare specialists. Nat. Med. 18:1000.
40. Weber, G. F., Chousterman, B. G., Hilgendorf, I. et al. 2014. Pleural innate response activator B cells protect against pneumonia via a GM-CSF-IgM axis. J. Exp. Med. 211:1243.
41. Jantz, M. A. and Antony, V. B. 2008. Pathophysiology of the pleura. Respiration 75:121.
42. Teng, R., Johkura, K., Ogiwara, N. et al. 2003. Morphological analysis of leucocyte transmigration in the pleural cavity. J. Anat. 203:391.
43. Hilgendorf, I., Theurl, I., Gerhardt, L. M. et al. 2014. Innate response activator B cells aggravate atherosclerosis by stimulating T helper-1 adaptive immunity. Circulation 129:1677.
44. Libby, P., Ridker, P. M. and Hansson, G. K. 2009. Inflammation in atherosclerosis: from pathophysiology to practice. J. Am. Coll. Cardiol. 54:2129.
45. Weber, C. and Noels, H. 2011. Atherosclerosis: current pathogenesis and therapeutic options. Nat. Med. 17:1410.
46. Swirski, F. K. and Nahrendorf, M. 2013. Leukocyte behavior in atherosclerosis, myocardial infarction, and heart failure. Science 339:161.
47. Bloom, D. E., Cafiero, E. T., Jane-Llopis, E. et al. 2012. The Global Economic Burden of Noncommunicable Diseases. Record no 90. Program on the Global Demography of Aging. World Economic Forum, Geneva.
48. Binder, C. J. 2012. Naturally occurring IgM antibodies to oxidation-specific epitopes. Adv. Exp. Med. Biol. 750:2.
49. Tsiantoulas, D., Gruber, S. and Binder, C. J. 2012. B-1 cell immunoglobulin directed against oxidation-specific epitopes. Front. Immunol. 3:415.
50. Wang, M., Subramanian, M., Abramowicz, S. et al. 2014. Interleukin-3/granulocyte macrophage colony-stimulating factor receptor promotes stem cell expansion, monocytosis, and atheroma macrophage burden in mice with hematopoietic ApoE deficiency. Arterioscler. Thromb. Vasc. Biol. 34:976.
51. Robbins, C. S., Chudnovskiy, A., Rauch, P. J. et al. 2012. Extramedullary hematopoiesis generates Ly-6C(high) monocytes that infiltrate atherosclerotic lesions. Circulation 125:364.
52. Swirski, F. K., Nahrendorf, M., Etzrodt, M. et al. 2009. Identification of splenic reservoir monocytes and their deployment to inflammatory sites. Science 325:612.
53. Hapel, A. J., Lee, J. C., Farrar, W. L. and Ihle, J. N. 1981. Establishment of continuous cultures of thy1.2+, Lyt1+, 2-T cells with purified interleukin 3. Cell 25:179.
54. Ihle, J. N., Pepersack, L. and Rebar, L. 1981. Regulation of T cell differentiation: in vitro induction of 20 alpha-hydroxysteroid dehydrogenase in splenic lymphocytes from athymic mice by a unique lymphokine. J. Immunol. 126:2184.
55. Yang, Y. C., Ciarletta, A. B., Temple, P. A. et al. 1986. Human IL-3 (multi-CSF): identification by expression cloning of a novel hematopoietic growth factor related to murine IL-3. Cell 47:3.
56. Williams, G. T., Smith, C. A., Spooncer, E., Dexter, T. M. and Taylor, D. R. 1990. Haemopoietic colony stimulating factors promote cell survival by suppressing apoptosis. Nature 343:76.
57. Weber, G. F., Chousterman, B. G., He, S. et al. 2015. Interleukin-3 amplifies acute inflammation and is a potential therapeutic target in sepsis. Science 347:1260.
58. Mortha, A., Chudnovskiy, A., Hashimoto, D. et al. 2014. Microbiotadependent crosstalk between macrophages and ILC3 promotes intestinal homeostasis. Science. 343:1249288.
59. Huffman, J. A., Hull, W. M., Dranoff, G., Mulligan, R. C. and Whitsett, J. A. 1996. Pulmonary epithelial cell expression of GM-CSF corrects the alveolar proteinosis in GM-CSF-deficient mice. J. Clin. Invest. 97:649.